First Capital Advisors Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | $535K | Sell |
6,947
-120
| -2% | -$9.25K | 0.28% | 71 |
|
2023
Q1 | $586K | Buy |
7,067
+22
| +0.3% | +$1.83K | 0.38% | 67 |
|
2022
Q4 | $605K | Sell |
7,045
-1,086
| -13% | -$93.2K | 0.41% | 68 |
|
2022
Q3 | $502K | Buy |
8,131
+1,185
| +17% | +$73.2K | 0.42% | 66 |
|
2022
Q2 | $429K | Buy |
+6,946
| New | +$429K | 0.29% | 83 |
|
2018
Q4 | $497K | Sell |
7,945
-1,323
| -14% | -$82.8K | 0.37% | 60 |
|
2018
Q3 | $716K | Buy |
9,268
+398
| +4% | +$30.7K | 0.44% | 50 |
|
2018
Q2 | $628K | Buy |
8,870
+1,150
| +15% | +$81.4K | 0.42% | 54 |
|
2018
Q1 | $582K | Sell |
7,720
-137
| -2% | -$10.3K | 0.34% | 66 |
|
2017
Q4 | $563K | Buy |
7,857
+653
| +9% | +$46.8K | 0.36% | 74 |
|
2017
Q3 | $584K | Buy |
7,204
+2,442
| +51% | +$198K | 0.4% | 69 |
|
2017
Q2 | $337K | Buy |
+4,762
| New | +$337K | 0.23% | 110 |
|